POET Technologies (POET) Stock Jumps 30% on Lumilens AI Deal

TLDR

• POET Technologies surged over 10% after announcing a $50M initial order from Lumilens, with potential to scale above $500M over five years.
• The company raised US$400M in a direct offering with a single institution, giving it $825M in cash to fund a 10x capacity expansion.
• Q1 2026 revenue was only ~$0.5M against a net loss above $12M, making this a pure growth/story stock.
• Semiconductor veteran Dr. Sandeep Kumar was hired as COO to lead manufacturing scale-up at Malaysian contract facilities.
• Stock jumped 30%+ on the Lumilens news before pulling back ~10% on dilution concerns from the capital raise.

---

POET Technologies (POET) is one of the hottest momentum names in AI hardware right now, and the last few weeks explain why.

POET Technologies Inc., POET

The stock opened near $11.98 on June 1, pushed to a $14.37 intraday high, and settled around $13.66. That’s a wide range, and it tells you exactly who is in control — momentum traders, dip buyers, and squeezed shorts.

Since early April, when the stock was trading around $6.11, POET has hit an intraday high of $20.81. The ride has been anything but smooth.

The catalyst everyone is focused on is the Lumilens deal. Lumilens is a venture-backed startup, founded in 2024 and backed by Mayfield and Spark Capital, building silicon photonics and optical interconnects for AI data centers and GPU clusters.

POET signed a supply and technology agreement with Lumilens that includes a $50M initial purchase order for its Electrical-Optical Interposer engines. Management says that order could scale above $500M over five years.

For a company that printed roughly $0.5M in quarterly revenue, that’s not a small deal.

The Lumilens founding team carries weight too. Its CEO previously founded Contrail Systems and Volterra, both acquired by major networking players. The company already has hyperscalers as customers, and analysts believe POET is supplying product to at least one of them through Lumilens.

Traders reacted fast when the news hit in mid-May — POET ripped 30% to 39% on heavy volume. That’s a full re-rating of the business model, not a one-day trade.

$400M Capital Raise Adds Fuel and Friction

Days after the Lumilens euphoria, POET raised US$400M via a registered direct offering with a single institutional investor, MMCAP, priced at roughly $21 per security with three-year warrants at a 25% premium strike.

The stock dropped about 10% on the news as traders weighed dilution against the capital firepower. That tug-of-war is the whole game with POET right now.

Post-raise, POET now holds $825M in cash. The company has already put some of it to work — placing equipment orders to expand wafer production capacity by 10x, loaning $30M to a company with technology it wants, and investing $3M in Lessengers.

Management has also flagged potential acquisitions to build out its differentiated product strategy in high-speed transceivers and light sources.

Manufacturing Push Takes Center Stage

POET’s hiring of Dr. Sandeep Kumar as COO is a clear signal of where the company is headed. The former SVP at Silicon Labs is tasked with bringing semiconductor-grade manufacturing discipline to POET’s Malaysian contract operations.

Assembly and test work is currently split across two Malaysian partners. At least one of them has expressed interest in co-investing in expansion equipment for 2027 and 2028 volume requirements.

Revenue shipments are expected to begin in the second half of 2026, though management noted a few weeks of delay this quarter. New undisclosed customers are also in the pipeline alongside previously announced ones.

POET is also collaborating with LITEON and Lessengers, and is planning a U.S. redomiciling to place itself closer to AI and data center customers.

The current ratio sits above 35, debt is low, and the $400M raise gives POET long runway to execute on the Lumilens order and beyond.